Polaryx Therapeutics Inc (PLYX) Stock Price, Quote, News & History

PLYXNASDAQ
$2.09
0.15.03%
Last update: Aug 26, 9:28 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-5.81M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
14.05M
Free Cash Flow (TTM)
-5.81M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
8.24M

Analyst Trends and Forecast

1
Feb
2
Jul
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$99.32M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
9.07
Earnings Yield % (TTM)
-6.90%
Earnings Yield % (FWD)
-9.30%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.22

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$11.54M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$2.10
Close
-
Volume / Avg.
76.40K / 174.11K
Day Range
$1.98 - $2.10
52 Wk Range
1.85 - 48.91
Market Cap
$104.18M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
46
Short Interest
1.15%
Days to Cover
2.6

About

Sector
Health Care
Industry
Pharmaceuticals
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underly...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Polaryx Therapeutics (PLYX) stock?

A

You can purchase shares of Polaryx Therapeutics (NASDAQ:PLYX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Polaryx Therapeutics (PLYX) competitors?

Q

What is the forecast, or price target, for Polaryx Therapeutics (PLYX) stock?

A

Polaryx Therapeutics has a consensus price target of $7.50.

Q

What is the current price for Polaryx Therapeutics (PLYX)?

A

The stock price for Polaryx Therapeutics (NASDAQ: PLYX) is $2.09 last updated August 26, 2026 at 9:28 AM EDT.

Q

Does Polaryx Therapeutics (PLYX) pay a dividend?

A

There are no upcoming dividends for Polaryx Therapeutics.

Q

When is Polaryx Therapeutics (NASDAQ:PLYX) reporting earnings?

A

Polaryx Therapeutics does not have any upcoming earnings scheduled.

Q

Is Polaryx Therapeutics (PLYX) going to split?

A

There is no upcoming split for Polaryx Therapeutics.

Q

What sector and industry does Polaryx Therapeutics (PLYX) operate in?

A

Polaryx Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.